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Endometriosis, defined as the presence of viable 
endometrial-like tissues, including glands and 
stroma outside the uterine cavity, is associated 
with pelvic pain, dysmenorrhea and infertility (1). 
Endometriosis is histologically categorized into 
Abstract 
Background: We aimed to examine resveratrol effects on gene expression of Bcl-2, Bax and Bcl-2/Bax ratio in 
endometrial stromal cells derived from women with and without endometriosis.  
Methods: Endometrial tissues were obtained from 40 endometriotic patients and 15 non-endometriotic controls 
undergoing laparoscopic surgery or hysterectomy in the gynecology ward of Rassoul Akram Hospital, Tehran, 
Iran from 2015 to 2017. After the enzymatic digestion, eutopic (EuESCs) and ectopic (EESCs) endometrial 
stromal cells from patients with endometriosis as well as endometrial stromal cells from non-endometriotic con-
trols (CESCs) were treated with or without resveratrol (100 µM) and the levels of Bcl-2, Bax and Bcl-2/Bax gene 
expression ratio in the cells from all origins were examined at 6, 24 and 48 h post-treatment by real-time PCR.  
Results: Resveratrol treatment increased Bcl-2 expression in CESCs at 24 and 48 h and in EuESCs at 48 h 
(P<0.05), but had no significant effects on the expression of this gene in EESCs. On the other hand, resveratrol 
treatment increased Bax expression in EuESCs at 6 h and decreased its expression in EESCs at 48 h (P<0.05). 
Regarding the Bcl-2/Bax gene expression ratio, resveratrol treatment increased Bcl-2/Bax gene expression ratio 
in CESCs and EuESCs at 48 h (P<0.01). However, this treatment had no significant differential effect on Bcl-2 
and Bcl-2/Bax gene expression ratio between CESCs and EuESCs at 48 h.  
Conclusion: Resveratrol treatment significantly increased Bcl-2/Bax gene expression ratio in EuESCs and 
CESCs but had no significant effect in EESCs. 
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three distinct forms: ovarian endometriosis (endo-
metrioma), peritoneal endometriosis and deeply 
infiltrating endometriosis (DIP) (2). Regardless of 
being a common and serious health problem in 
women, the exact etiology of endometriosis re-
mains unclear. Based on published studies, retro-
grade menstruation (Sampson theory) of endome-
trial cells with subsequent implantation and 
growth of viable endometrium within the perito-
neal cavity have an important role in triggering and 
developing the disease (1). Ample evidence indi-
cates that the endometrial cells from women with 
and without endometriosis have different capaci-
ties to invade apoptosis (3), proliferate, implant 
and survive in the ectopic locations (4).  
Apoptosis in the eutopic endometrium of endo-
metriotic patients was lower compared to non-en-
dometriotic patients. Moreover, ectopic endome-
trium of endometriotic patients showed less apop-
tosis compared with their eutopic counterparts (3, 
5). Besides, early studies provided conflicting data 
concerning the difference in anti-apoptotic B-cell 
lymphoma/leukemia-2 (Bcl-2) and pro-apoptotic 
Bax gene expression between normal endometrial 
tissue and eutopic and/or ectopic endometrial tis-
sue in endometriotic women (6). Therefore, ma-
nipulation of programmed cell death processes by 
enhancing endogenous or exogenous apoptotic 
stimulants in the lesions could be used to treat en-
dometriosis. 
In recent years, naturally occurring phytochemi-
cals such as resveratrol have gained considerable 
attention because of their health-promoting prop-
erties (7). Resveratrol (trans-3,4',5-trihydroxystil-
bene, C14H12O3) is a phytoalexin synthesized by 
plants in response to fungal infection or exposure 
to ultraviolet light and is present in dietary prod-
ucts such as grapes and red wine (8). In the last 
few decades, resveratrol and other stilbenes have 
gained considerable attention, particularly in in-
vitro and preclinical studies due to their antioxi-
dant, anti-inflammatory, anti-neoplastic and other 
health-promoting effects (9).  
Therapeutic effects of resveratrol on endometrio-
sis was first described by Bruner-Tran et al in 2011 
(10). From that moment, the interest in this natu-
ral compound has grown extremely and many re-
searchers tried to find protective mechanisms of 
resveratrol on endometriosis. Resveratrol controls 
the development of endometriosis by suppression 
of proliferation in endometriotic lesions (10, 11), 
induction of apoptosis (10, 11), reduction of in-
flammation (12, 13), angiogenesis (12, 14, 15) and 
oxidative stress (16). With regard to apoptosis, 
previous studies examined the effects of resvera-
trol on experimental endometriotic mice models 
gained conflicting results (10, 11, 17). However, 
the effect of resveratrol treatment on apoptosis in 
endometriotic stromal cells was examined in just 
one study (18). In that study, resveratrol treatment 
did not induce apoptosis in endometriotic stromal 
cells.  
These findings encouraged us to investigate the 
gene expression of Bcl-2, Bax and Bcl-2/Bax ratio 
in eutopic (EuESCs) and ectopic (EESCs) endo-
metrial stromal cells from patients with peritoneal 
endometriosis and endometrial stromal cells from 
non-endometriotic controls (CESCs). 
 
Materials and Methods 
 
Patient recruitment and sample collection 
Forty women with peritoneal endometriosis and 
15 women without endometriosis who underwent 
laparoscopic surgery or hysterectomy in the gyne-
cology ward of Rassoul Akram Hospital, Tehran, 
Iran (January 2015 to April 2017) were enrolled in 
this study. All eligible women were of reproduc-
tive age (19-45 yr old), at the proliferative phase of 
the menstrual cycle, had normal menstrual cycles 
and had no history of hormonal treatment, preg-
nancy, breastfeeding, or using antioxidant supple-
ments within the last three months before sam-
pling. Patients with pelvic inflammatory disease, 
adenomyosis and suspected or ascertained diagno-
sis of malignancy were excluded. All patients with 
endometriosis were classified into stage III-IV ac-
cording to the revised American Fertility Society 
system (19).  
All experimental procedures were approved by 
Human Ethics Committees of the Iran University 
of Medical Sciences (No: 
IR.IUMS.REC.1395.28108) and signed informed 
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consent was obtained from each participant be-
fore enrolling in the study. 
Ectopic and eutopic endometrial samples were 
obtained through laparoscopic sampling and bi-
opsy curette, respectively. In parallel, small frag-
ment of the excised tissues were examined histo-
logically for confirmation of endometriosis. 
 
Isolation of endometrial stromal cells (ESCs) 
and cell culture 
Fresh endometriotic tissues were collected in ster-
ile Dulbecco’s modified Eagle’s medium (DMEM) 
–F12 (Gibco, Grand Island, NY, USA) containing 
antibiotics and immediately transferred in cold 
chain to the laboratory, where minced into small 
pieces and digested at 37 °C for 120 min in 
DMEM/F-12 containing 100 U/ml penicillin and 
100 µg/ml streptomycin, 2 mg/ml of type I colla-
genase (Sigma-Aldrich, St Louis, MO, USA) and 
300 µg/ml of deoxynuclease I (Takara, Tokyo, Ja-
pan) with intermittent vortexing every 15 min (20). 
The obtained ESCs were then cultured and al-
lowed to propagate not beyond passage three. 
Some samples were lost due to contamination or 
absence of enough cell growth especially in case of 
EESCs. Finally, cells from 13 eutopic and 11 ec-
topic endometrial tissues of endometriotic pa-
tients and 11 eutopic endometrial tissue from non-
endometriotic patients were used in this study. Pu-
rity of isolated ESCs was assessed by flowcytomet-
ric analysis using a panel of antibodies. The ESCs 
were characterized as CD10+, CD73+, CD105+, 
CD44+, CD34- and CD45- cells. 
 
MTT assay 
To investigate the safety dose of resveratrol, me-
thyl thiazolyl tetrazolium (MTT) (Danesh Azma, 
Iran) assay was performed (21). Resveratrol 
(Sigma-Aldrich, St Louis, MO, USA) was dis-
solved in ethanol. Approximately 2×104/well 
EuESCs from 4 endometriotic patients were 
seeded in duplicate in 96-well plates (SPL, Korea) 
and cultured for 24 h. After this time, EuESCs 
were treated in the presence or absence of resvera-
trol (12.5, 25, 50, 100, 200 and 400 µM). One h 
later, cells were stimulated with lipopolysaccharide 
(LPS) (100 ng/ml) (22, 23) as an inducer of apop-
tosis (24) and incubated in an incubator at 37 °C in 
a humidified, 5% CO2. The cytotoxic activity was 
determined after 24 and 48 h. Following 24 h in-
cubation period, the medium was removed and 
100 μl of fresh medium containing 12 mM MTT 
stock solution was added to all wells and plates 
were incubated for 4 h at 37 °C. Thereafter, me-
dium was removed from the wells and 50 μl of 
MTT solvent was added to each well. After ensur-
ing that all formazan crystals were dissolved, the 
absorbance was measured at 570 nm using a mi-
croplate ELISA reader (Bio-Tek Instruments Inc., 
Vermont, USA). The viability of the cells calcu-
lated using the following equation: 
%Viability= [(OD of treated cells-OD of MTT 
solvent) / (OD of untreated cells-OD of MTT 
solvent)] ×100 
 
Treatment of ESCs with resveratrol 
In a pilot study, different concentrations of 
resveratrol ranging from 25–100 µM and also the 
time interval for the addition of LPS to the 
resveratrol-treated cells were set up. A collectively 
concentration of 100 µM for resveratrol was se-
lected because this concentration has been shown 
to suppress cell proliferation or modulate bio-
chemical processes in cancer cell lines (25). Thus, 
30×104/well ESCs were seeded in 24-well plates 
and after 3 h, cells were treated with 100 µM 
resveratrol or ethanol as vehicle control. One h 
later, 100 ng/ml LPS (23) was added to each well 
and cells were incubated for 6, 24 and 48 h. 
 
RNA extraction and cDNA synthesis 
Total RNA from treated and untreated ESCs were 
extracted using the TRIZOL reagent (QIAGEN, 
Germany) according to the supplier’s protocol. 
The quantity of the extracted RNA was deter-
mined at an absorbance wavelength of 260/280 
using a NanoDrop 2000 spectrophotometer 
(Thermo Fisher Scientific, Waltham, MA, USA). 
Reverse transcription of RNA (1 μg) was per-
formed using a Revert Aid First Strand cDNA 
Synthesis Kit (Thermo Fisher Scientific, Waltham, 
MA, USA) according to the manufacturer’s in-
structions. The expressions of the genes of interest 
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were normalized using glyceraldehyde 3‐phos-
phate dehydrogenase (GAPDH) as a housekeep-
ing gene. The following primers and annealing 
temperatures were used for amplification; Bcl-2: 
forward primer (F) 5’- ATCGCCCTGTG-
GATGACTGAGT-3’ and reverse primer (R) 5’- 
GCCAGGAGAAATCAAACAGAGGC-3’ 
(62°C) (26); Bax: (F) 5’-CCCTTTT-
GCTTCAGGGTTTCATCCA-3’ and (R) 5’-
CTTGAGACACTCGCTCAGCTTCTTG-3’ 
(60°C) (27); GAPDH: (F) 5’- GCA CCG TCA 
AGG CTG AGA AC-3’ and (R) 5’- TGG TGA 
AGA CGC CAG TGG A-3’ (58°C) (28). The tem-
plate and primer pairs were mixed with SYBER 
Green PCR Master Mix (BioFACT, South Korea) 
and real-time PCR was performed using a Rotor-
Gene 3000 (Corbett Research, Sydney, Australia) 
with preliminary hold at 95 °C for 15 min, fol-
lowed by 40 cycles of 95 °C for 20 sec, annealing 
and elongation for 40 sec and finally melting step 
was from 60 to 99 °C. Melting curve analysis was 




The statistical analysis of data was performed us-
ing GraphPad Prism software (ver. 6). The Kol-
mogorov–Smirnov distribution test was used in 
order to assess data normality. Based on the non-
parametric distribution of data, Wilcoxon and 
Mann-Whitney U tests were used for comparison 
of variables within and between groups, respec-
tively. For the comparison of more than two inde-
pendent variables, Kruskal–Wallis test was used. 
In the case of significant differences between the 
study groups, differential effect was applied. P-





The effect of resveratrol on EuESCs viability 
The viability of EuESCs was determined by MTT 
assay. Cells were treated with resveratrol (12.5-400 
µM) for 24 and 48 h. Resveratrol treatment with 
concentrations lower than 100 µM for up to 48 h 
had no effect on EuESCs viability while treatment 
of these cells with 200 µM of resveratrol for 48 h, 





Fig. 1: The effect of resveratrol on EuESCs viability. 
EuESCs were treated with and without resveratrol (12.5-
400 µM) for 24 and 48 h in the presence of LPS (100 
ng/ml). Cell viability was examined by MTT assays. 
Data were represented as medians (interquartile range) 
of two separate experiments. Statistical comparisons 
were made by an analysis of variance (two-way 
ANOVA), with a 95% confidence interval followed by 
Tukey post hoc test to identify significant differences 
between mean values of the target cells and the controls. 
In the figure, “a” indicates “no significant differences”; 
while “***” indicates “P < 0.001”. EuESCs, eutopic en-
dometrial stromal cells; LPS, lipopolysaccharide; MTT, 
methylthiazolyl tetrazolium 
 
The effect of resveratrol on Bcl-2 gene expres-
sion  
As Fig 2 shows, resveratrol treatment increased 
Bcl-2 gene expression in CESCs at 24 (P<0.05; 
Fig. 2B) and 48 h (P<0.01; Fig. 2C) and in EuESCs 
at 48 h (P<0.01; Fig. 2C), but had no significant 
effects on the expression of this gene in EESCs. 
Furthermore, resveratrol treatment had no signif-
icant differential effect on increased Bcl-2 gene ex-
pression between EuESCs and CESCs at 48 h 
(Fig. 2D). 
 
The effect of resveratrol on Bax gene expres-
sion  
Resveratrol treatment increased Bax gene expres-
sion in EuESCs at 6 h (P<0.05; Fig. 3A) and de-
creased its expression in EESCs at 48 h (P<0.05; 
Fig. 3C). 
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Fig. 2: Quantitative RT-PCR gene expression of Bcl-2 in CESCs, EuESCs and EESCs treated with or without 
resveratrol for 6, 24 and 48 h. CESCs from non-endometriotic controls (n = 11), EuESCs (n = 13) and EESCs (n = 
11) from endometriotic patients were cultured in the presence or absence of resveratrol for 6 (A), 24 (B) and 48 h 
(C). The bar graph indicates the fold change of Bcl-2 mRNA expression. (D) Differential effect of resveratrol on 
EuESCs and CESCs at 48 h were calculated as the ratio of Bcl-2 gene expression in the presence and absence of 
resveratrol. Data are expressed as means ± SEM. *P<0.05, **P<0.01. CESCs, control endometrial stromal cells; 





Fig. 3: Quantitative RT-PCR gene expression of Bax in CESCs, EuESCs and EESCs treated with or without 
resveratrol for 6, 24 and 48 h. CESCs from non-endometriotic controls (n = 11), EuESCs (n = 13) and EESCs (n = 
11) from endometriotic patients were cultured in the presence or absence of resveratrol for 6 (A), 24 (B) and 48 h 
(C). The bar graph indicates the fold change of Bax mRNA expression. Data are expressed as means ± SEM. Statis-
tical comparisons were made by Wilcoxon matched-pairs signed rank test. *P < 0.05. CESCs, control endometrial 
stromal cells; EuESCs, eutopic endometrial stromal cells; EESCs, ectopic endometrial stromal cells 
 
The effect of resveratrol on Bcl-2/Bax gene 
expression ratio 
Resveratrol treatment increased Bcl-2/Bax gene 
expression ratio in CESCs and EuESCs at 48 h 
(P<0.01 and P≤0.001 respectively; Fig. 4C) but 
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had no significant effect on Bcl-2/Bax gene ex-
pression ratio in EESCs (Fig. 4). Besides, resvera-
trol treatment had no significant differential effect 
on increased Bcl-2/Bax gene expression ratio be-
tween EuESCs and CESCs at 48 h (Fig.  4D). 
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Fig. 4: Quantitative RT-PCR gene expression of Bcl-2/Bax ratio in CESCs, EuESCs and EESCs treated with or without 
resveratrol for 6, 24 and 48 h. CESCs from non-endometriotic controls (n = 11), EuESCs (n = 13) and EESCs (n = 11) 
from endometriotic patients were cultured in the presence or absence of resveratrol for 6 (A), 24 (B) and 48 h (C). The bar 
graph indicates the fold change of Bcl-2/Bax mRNA expression ratio. (D) Differential effect of resveratrol on EuESCs 
and CESCs at 48 h were calculated as the ratio of Bcl-2/Bax gene expression in the presence and absence of resveratrol. 
Data were represented as mean ± SEM. **P < 0.01 and ***P ≤ 0.001. CESCs, control endometrial stromal cells; EuESCs, 




In this study, resveratrol treatment increased Bcl-
2/Bax gene expression ratio in EuESCs and 
CESCs. To our knowledge, this is the first report 
evaluating the effects of resveratrol on apoptosis 
by investigating Bcl-2, Bax and Bcl-2/Bax gene ex-
pression ratio in ESCs. Resveratrol has been re-
ported to exert a variety of biological effects, but 
the underlying mechanisms regarding apoptosis 
are not well understood. Recently, conflicting re-
sults were reported regarding induction of apop-
tosis by resveratrol in endometriosis (10, 11, 17, 
18). Bruner-Tran et al. have recently demonstrated 
that resveratrol increased TUNEL staining of en-
dometrial implants (10). Besides, BALB/c mice 
underwent surgical induction of endometriosis. 
Resveratrol treatment in this study, significantly 
increased apoptosis in the lesions (11). On the 
other hand, in a randomized study in a mouse 
model of endometriosis, resveratrol treatment had 
no effect on caspase-3-positive apoptotic cells in 
endometriotic lesions (17). Besides, resveratrol 
treatment did not induce apoptosis measured by 
annexin V-FITC in endometriotic stromal cells 
(18). On the other hand, in our study resveratrol 
treatment significantly increased Bcl-2/Bax gene 
expression ratio in EuESCs and CESCs.  
One explanation for such differing results could 
be explained by possible differences in the meth-
odology. In animal models of endometriosis, en-
dometriotic lesions were induced differently. 
Some induced endometriotic lesions surgically us-
ing endometrial tissues from women without en-
dometriosis (10) or used uterine tissue from donor 
mice into the peritoneal cavity of recipient mice 
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without using endometriotic tissue of human 
origin (17). Endometrium from women with en-
dometriosis and endometriotic implants have 
some major differences compared with the normal 
endometrium of non-endometriotic women (29). 
Furthermore, induction of apoptosis observed in 
mouse model of endometriosis, was not the direct 
result of resveratrol, but was secondary to the ef-
fect of resveratrol on suppression of vasculariza-
tion (11,17) and invasiveness (10). 
There is a plethora of evidence suggesting an up-
regulation of anti-apoptotic genes and reciprocal 
down-regulation of the genes regulating the apop-
tosis pathway in endometriotic stromal cells and 
resistance of these cells to apoptosis (30). Besides 
apoptosis, oxidative stress plays an important role 
in endometriosis (31). Presence of macrophages, 
iron or environmental contaminants in the perito-
neal fluid of some women leading to oxidative 
stress, tissue growth and endometriosis (32). Fur-
thermore, positive association between oxidative 
stress and endometriosis have been found in some 
studies (31). Increase in reactive oxygen species 
(ROS) production is associated with apoptosis 
(33). However, the magnitude of this effect will 
depend upon the cellular genetic background, the 
types and levels of the specific ROS involved and 
duration of the oxidative stress (34). On the other 
hand, many inhibitors of apoptosis have antioxi-
dant activities or enhance cellular antioxidant de-
fenses (35). Diets depleted of the antioxidants se-
lenium and α-tocopherol were enhanced apoptosis 
and inhibited brain tumor growth in transgenic 
mice model (36). In our study resveratrol as a po-
tent inhibitor of ROS production (37), increased 
Bcl-2/Bax gene expression ratio in EuESCs and 
CESCs. Similarly, in other studies resveratrol treat-
ment attenuated oxidative stress-induced cell death 
in cultured rat pheochromocytoma (PC12) cells 
(38) and human neuroblastoma cell line SH-SY5Y 
(39). 
Another explanation for our findings could be ex-
plained by the role played by growth factors as an 
epidermal growth factor (EGF) and other growth 
factors stimulate endometriotic stromal cell’s 
growth (40) and inhibit resveratrol’s action on 
both ERK1/2 activation and the induction of 
apoptosis via the p53 pathway in cancer cells (41). 
On the other hand, EESCs and EuESCs altered 
responses to apoptosis in our study could be ex-
plained by differences in the microenvironment 
and inflammatory condition of peritoneal cavity of 
endometriotic patients that affecting endometri-
otic cell’s responses to nutritional interventions 
(20, 26).  
A key strength of this study is that we used a large 
sample of the study subjects, and all our patients 
were examined in the same phase of the menstrual 
cycle. However, there are some limitations in our 
study. First, it may be essential to evaluate resvera-
trol effect in combination with other antioxidants 
in a long period of time. The second limitation was 
that we did not assess protein expression of apop-




Resveratrol treatment increased Bcl-2/Bax gene ex-
pression ratio in EuESCs and CESCs but had no ef-
fect on EESCs. Although apoptosis has an im-
portant role in pathophysiology of endometriosis, 
but further in vitro and in vivo studies are warranted 
to fully investigate resveratrol effects on cell prolifer-
ation, invasion, adhesion and other factors related to 
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